From Casetext: Smarter Legal Research

Takeda Pharms. Co. v. Zydus Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Dec 7, 2012
2013-1089 (Fed. Cir. Dec. 7, 2012)

Opinion

2013-1089

12-07-2012

TAKEDA PHARMACEUTICALS COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS, LLC, TAKEDA PHARMACEUTICALS AMERICA, INC., AND ETHYPHARM, S.A., Plaintiffs-Appellees, v. ZYDUS PHARMACEUTICALS USA, INC. AND CADILA HEALTHCARE, LIMITED, Defendants-Appellants.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of New Jersey in case no. 10-CV-1723, Judge Joel A. Pisano.

ON MOTION


ORDER

The appellants move to expedite briefing and argument.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion to expedite briefing is granted to the following extent: The appellants' opening brief is due December 17. The appellees' brief is due January 2, 2013. The appellants' reply brief and the joint appendix are due January 9, 2013.

(2) Oral argument will be scheduled by subsequent order of the court.

FOR THE COURT

______________________

Jan Horbaly

Clerk
s8


Summaries of

Takeda Pharms. Co. v. Zydus Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Dec 7, 2012
2013-1089 (Fed. Cir. Dec. 7, 2012)
Case details for

Takeda Pharms. Co. v. Zydus Pharms. USA, Inc.

Case Details

Full title:TAKEDA PHARMACEUTICALS COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH…

Court:United States Court of Appeals for the Federal Circuit

Date published: Dec 7, 2012

Citations

2013-1089 (Fed. Cir. Dec. 7, 2012)